Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$775,400
-$135,796 QoQ
Shares Held
32,201
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,470
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SMITH, MOORE & CO. holds $27,430,178 across 9 Drug Manufacturers - General names. PFE ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,543 | $7,182,560 | |
| 2 | LLY |
ELI LILLY & Co
|
5,912 | $7,091,030 | |
| 3 | JNJ |
Johnson & Johnson
|
23,180 | $5,887,024 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,976 | $3,080,916 | |
| 5 | AMGN |
Amgen Inc
|
4,729 | $1,712,465 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,730 | $906,362 | |
| 7 | PFE |
Pfizer Inc
This page
|
32,201 | $775,400 | |
| 8 | AZN |
Astrazeneca PLC
|
2,644 | $501,355 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $775,400 | 32,201 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $911,196 | 32,450 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $856,858 | 34,412 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,018,257 | 39,963 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,051,482 | 43,378 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,092,762 | 43,124 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,213,986 | 45,759 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,801,080 | 62,235 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,777,177 | 63,516 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,701,408 | 61,312 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,613,420 | 56,041 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,105,100 | 63,464 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,360,284 | 64,348 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,555,140 | 62,626 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,241,134 | 63,254 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,820,944 | 64,464 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,238,915 | 61,776 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,253,330 | 62,842 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,577,308 | 60,581 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,592,169 | 60,269 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,360,329 | 60,274 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,942,543 | 53,617 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,765,002 | 47,949 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,782,333 | 48,565 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,509,270 | 46,155 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,562,572 | 47,873 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||